The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis

Do proton pump inhibitors protect against cancer progression in GERD?

(2012) Tomoharu Miyashita et al.   SURGERY TODAY

Aryl Hydrocarbon Receptor Agonists Induce MicroRNA-335 Expression and Inhibit Lung Metastasis of Estrogen Receptor Negative Breast Cancer Cells

(2011) S. Zhang et al.   MOLECULAR CANCER THERAPEUTICS

Omeprazole Inhibits Proliferation and Modulates Autophagy in Pancreatic Cancer Cells

(2011) Andrej Udelnow et al.   PLoS One

Exactly the Same but Different: Promiscuity and Diversity in the Molecular Mechanisms of Action of the Aryl Hydrocarbon (Dioxin) Receptor

(2011) Michael S. Denison et al.   TOXICOLOGICAL SCIENCES

Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer

(2010) Venkateswaran Subramaniam et al.   ANTI-CANCER DRUGS

Development of a Selective Modulator of Aryl Hydrocarbon (Ah) Receptor Activity that Exhibits Anti-Inflammatory Properties

(2010) Iain A. Murray et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Tranilast treatment decreases cell growth, migration and inhibits colony formation of human breast cancer cells

(2010) Venkateswaran Subramaniam et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Aryl hydrocarbon receptor activation during pregnancy, and in adult nulliparous mice, delays the subsequent development of DMBA-induced mammary tumors

(2010) Tao Wang et al.   INTERNATIONAL JOURNAL OF CANCER

Mechanistic Insights into the Events That Lead to Synergistic Induction of Interleukin 6 Transcription upon Activation of the Aryl Hydrocarbon Receptor and Inflammatory Signaling

(2010) Brett C. DiNatale et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Suppression of Cytokine-Mediated Complement Factor Gene Expression through Selective Activation of the Ah Receptor with 3',4'-Dimethoxy- -naphthoflavone

(2010) I. A. Murray et al.   MOLECULAR PHARMACOLOGY

Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells

(2010) Anthony E. Boitano et al.   SCIENCE

Aryl Hydrocarbon Receptor Activation by TCDD Reduces Inflammation Associated with Crohn's Disease

(2010) Jenna M. Benson et al.   TOXICOLOGICAL SCIENCES

Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical Implications

(2009) Ramalinga R. Kedika et al.   DIGESTIVE DISEASES AND SCIENCES

The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy

(2009) Shu Zhang et al.   ENDOCRINE-RELATED CANCER

Activation of the Aryl-Hydrocarbon Receptor Inhibits Invasive and Metastatic Features of Human Breast Cancer Cells and Promotes Breast Cancer Cell Differentiation

(2009) Julie M. Hall et al.   MOLECULAR ENDOCRINOLOGY

Regulation of Aryl Hydrocarbon Receptor Function by Selective Estrogen Receptor Modulators

(2009) Carolyn D. DuSell et al.   MOLECULAR ENDOCRINOLOGY

Evidence for Ligand-Mediated Selective Modulation of Aryl Hydrocarbon Receptor Activity

(2009) I. A. Murray et al.   MOLECULAR PHARMACOLOGY

CXCR4 and CXCL12 down-regulation: A novel mechanism for the chemoprotection of 3,3′-diindolylmethane for breast and ovarian cancers

(2008) Erin L. Hsu et al.   CANCER LETTERS

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins

(2008) Marc Veldhoen et al.   NATURE

Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor

(2008) Francisco J. Quintana et al.   NATURE